Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
CYTOKERATIN CK 18 (M30): A Novel Biomarker in Acute Liver Failure
 
Chetanya Malik, Dhruv Ahuja, Rajib K Hazam, Premashis Kar
Department of Medicine, Maulana Azad Medical College, New Delhi, India. 


Corresponding Author
:
Dr. Premashis Kar
Email: premashishkar@gmail.com


Abstract

Backgrounds and Aims: Early liver transplant can significantly improve survival rates in acute liver failure. We assessed the role of apoptotic biomarker CK 18 in predicting disease outcome and prognosis.
Materials and Methods: We evaluated 45 ALF patients for CK 18 at day of admission and day 3 of hospital course. A prognostic model formulated using biochemical parameters and CK18 was assessed for prognosis and compared with established King’s College criteria and MELD score. 
Results: CK18 was significantly higher in non survivors. The prognostic equation predicted mortality with 94.4% sensitivity and 89.9% specificity. 
Conclusion: CK18 based prognostic equation predicts the outcomes and prognosis with higher specificity, accuracy and much earlier in disease course than King’s College Criteria and MELD scoring.